HC Wainwright & Co. Maintains Buy on 89bio, Lowers Price Target to $29
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Ed Arce maintains a Buy rating on 89bio (NASDAQ:ETNB) but lowers the price target from $31 to $29.
May 10, 2024 | 12:09 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
89bio's Buy rating is maintained by HC Wainwright & Co., though the price target is reduced from $31 to $29.
While the maintenance of a Buy rating indicates continued confidence in 89bio's potential, the reduction in price target could signal a tempered outlook on the stock's short-term price performance. This mixed signal might lead to neutral market reaction in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100